John M Gregory - Net Worth and Insider Trading

John M Gregory Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John M Gregory owns 3 companies in total, including Tribute Pharmaceuticals Canada Inc (TBUFF) , DMK Pharmaceuticals Corp (DMKPQ) , and Novavax Inc (NVAX) .

Click here to see the complete history of John M Gregory’s form 4 insider trades.

Insider Ownership Summary of John M Gregory

Ticker	Comapny	Transaction Date	Type of Owner
TBUFF	Tribute Pharmaceuticals Canada Inc	2013-06-28	director & 10 percent owner
DMKPQ	DMK Pharmaceuticals Corp	2004-01-27	10 percent owner
NVAX	Novavax Inc	2005-08-31	10 percent owner

John M Gregory Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

John M Gregory Ownership Network

Ownership Network List of John M Gregory

No Data

Ownership Network Relation of John M Gregory

John M Gregory Owned Company Details

What does Tribute Pharmaceuticals Canada Inc do?

Who are the key executives at Tribute Pharmaceuticals Canada Inc?

John M Gregory is the director & 10 percent owner of Tribute Pharmaceuticals Canada Inc. Other key executives at Tribute Pharmaceuticals Canada Inc include 10 percent owner Sj Strategic Investments Llc , other: Member Joan P Gregory , and other: Member James M Gregory .

Tribute Pharmaceuticals Canada Inc (TBUFF) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tribute Pharmaceuticals Canada Inc (TBUFF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tribute Pharmaceuticals Canada Inc (TBUFF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tribute Pharmaceuticals Canada Inc (TBUFF)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tribute Pharmaceuticals Canada Inc Insider Transactions

No Available Data

What does DMK Pharmaceuticals Corp do?

Who are the key executives at DMK Pharmaceuticals Corp?

John M Gregory is the 10 percent owner of DMK Pharmaceuticals Corp. Other key executives at DMK Pharmaceuticals Corp include General Counsel Dorbin John W. Jr. , CFO Seth Cohen , and director & CEO Ebrahim Versi .

DMK Pharmaceuticals Corp (DMKPQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of DMK Pharmaceuticals Corp (DMKPQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DMK Pharmaceuticals Corp (DMKPQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

DMK Pharmaceuticals Corp (DMKPQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

DMK Pharmaceuticals Corp Insider Transactions

No Available Data

What does Novavax Inc do?

Who are the key executives at Novavax Inc?

John M Gregory is the 10 percent owner of Novavax Inc. Other key executives at Novavax Inc include President & R&D Filip Dubovsky , President & R&D Gregory M Glenn , and EVP & Chief Strategy Officer Elaine O'hara .

Novavax Inc (NVAX) Insider Trades Summary

Over the past 18 months, John M Gregory made no insider transaction in Novavax Inc (NVAX). Other recent insider transactions involving Novavax Inc (NVAX) include a net purchase of 6,000 shares made by Gregory M Glenn ,

In summary, during the past 3 months, insiders sold 0 shares of Novavax Inc (NVAX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Novavax Inc (NVAX) were sold and 6,000 shares were bought by its insiders, resulting in a net purchase of 6,000 shares.

Novavax Inc (NVAX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Novavax Inc Insider Transactions

No Available Data

John M Gregory Mailing Address

Above is the net worth, insider trading, and ownership report for John M Gregory. Currently GuruFocus does not have mailing address information for John M Gregory.

Discussions on John M Gregory

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.